Product correctly added to cart.

discount label
MCI 225
View 3D

Biosynth logo

MCI 225

CAS: 135991-48-9

Ref. 3D-KFA99148

10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Wednesday 22 Jan 2025

Product Information

Name:
MCI 225
Synonyms:
  • 4-(2-Fluorophenyl)-6-methyl-2-piperazinothieno[2,3-d]pyrimidine
  • 4-(2-Fluorophenyl)-6-Methyl-2-(Piperazin-1-Yl)Thieno[2,3-D]Pyrimidine
Description:

MCI 225 is a drug that belongs to the class of tricyclic antidepressants. It has been shown to be an effective treatment for depression and other psychiatric disorders. MCI 225 inhibits the uptake of serotonin, norepinephrine, and dopamine into the synaptic cleft by blocking the 5-HT3 receptor. This is thought to lead to increased levels of serotonin in the brain. MCI 225 also has anti-inflammatory properties and can be used in inflammatory bowel disease as well as bowel disease. MCI 225 may also have therapeutic effects on heart diseases or cancer due to its anti-inflammatory properties. Clinical use of this drug is limited due to its low potency, but it has been found to be better tolerated than other tricyclic antidepressants with similar activity.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
328.4 g/mol
Formula:
C17H17FN4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-KFA99148 MCI 225

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".